Wendtner, Clemens-Martin (2014). Otlertuzumab more than a TRU(E) toddler in CLL? Blood, 123 (9). S. 1282 - 1287. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Full text not available from this repository.Abstract
In this issue of Blood, Byrd et al present first-in-man data in chronic lymphocytic leukemia (CLL) using otlertuzumab (TRU-016), a fully humanized anti-CD37 protein therapeutic. Although this novel immunotherapeutic shows modest single-agent activity, combinations with phosphatidylinositol-3-kinase (PI3K) inhibitors might open new future perspectives.
| Item Type: | Journal Article | ||||||||
| Creators: |
|
||||||||
| URN: | urn:nbn:de:hbz:38-445663 | ||||||||
| DOI: | 10.1182/blood-2014-01-548560 | ||||||||
| Journal or Publication Title: | Blood | ||||||||
| Volume: | 123 | ||||||||
| Number: | 9 | ||||||||
| Page Range: | S. 1282 - 1287 | ||||||||
| Date: | 2014 | ||||||||
| Publisher: | AMER SOC HEMATOLOGY | ||||||||
| Place of Publication: | WASHINGTON | ||||||||
| ISSN: | 1528-0020 | ||||||||
| Language: | English | ||||||||
| Faculty: | Unspecified | ||||||||
| Divisions: | Unspecified | ||||||||
| Subjects: | no entry | ||||||||
| Uncontrolled Keywords: |
|
||||||||
| URI: | http://kups.ub.uni-koeln.de/id/eprint/44566 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
 |
View Item |